Analysis of risk factors and mortality from community-acquired pneumoniain the conditions of a city hospital

The article presents the results of an analysis of medical histories of patients in a hospital of a therapeutic profile who died as a result of communityacquired pneumonia. Risk factors and frequent complications leading to death from community-acquired pneumonia have been identifiedВ статье представлены результаты анализа историй болезни пациентов терапевтического стационара, умерших в результате внебольничной пневмонии. Выявлены факторы риска и ведущие осложнения, приводящие к летальному исходу от внебольничной пневмони

Effects of the element separation on the noise performance of receiving antenna arrays

Antenna arrays of closely separated elements can be used to achieve a large field of view of a radio telescope with highly efficient multiple beams. However, due to strong mutual coupling effects which exist in such dense arrays, the receiver noise can degrade. To reduce this noise degradation, the optimal noise match condition should be satisfied for all scan angles. This paper presents results of the noise performance analysis of small arrays of dipoles that were obtained for several element separation distances covering both conventional and dense arrays. The receiver noise temperatures are calculated for different noise match situations and the minimum noise temperature conditions are discussed

Industrial Internet of things: concept and legal consciousness, meaning for industry 4.0

The paper presents the author's concept for describing and explaning the essence and advantages of the industrial internet of things. The authors show the importance and perspectives of the industrial internet of things for industry 4.

Analysis of large microstrip-fed tapered slot antenna arrays by combining electrodynamic and quasi-static field models

A reduced-order model for large arrays of microstrip-fed tapered slot antennas (TSAs) is presented. The currents on the antenna conductors are modeled by a relatively small number of physics-based macro-domain basis functions through a technique which is known as the characteristic basis function method (CBFM). The array is treated as a metal-only structure, while the wideband microstrip feeds are separately modeled using quasi-static circuit models. It is demonstrated that, even though the dielectric-supported feeds are non-shielded and therefore form an integral part of each radiating antenna element, the feeds can be modeled independently from the strongly coupled antenna elements. Validation of the combined antenna-feed model has been carried out through the measurements of several practically realized TSA arrays, among them a 8 7 7 7 2 dual-polarized array. The results demonstrate good agreement over a large scan range, as well as over a wide frequency band. The polarization-discrimination capabilities of the antenna, when operating in phased-array mode, have been analyzed in the context of radio-astronomical applications

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL

Aim. To evaluate antihypertensive and metabolic effects of the therapy based on carvedilol (C) in comparison with metoprolol (M) in hypertensive patients with overweight or obesity.Material and methods. 320 patients were involved in multicenter, randomized open parallel study. One part of the patients received C 12,5 mg BID (Vedicardol, “Sintez”), another part – M 25 mg/day BID. Doubling dose of β-blockers (BB) and switching patients to combined therapy with AML 5-10 mg OD (Amlorus, “Sintez”) and hydrochlorothiazide (HCT) 12,5-25 mg OD was performed if necessary. The study duration was 24 weeks.Results. Significant reduction of systolic and diastolic blood pressure was revealed in both groups, there was no difference between groups (р=0,88 and p=0,61 respectively). Switching patients to combined therapy with AML and HCT was made more often in M group than in C group (p&gt;0,05). Prescription of BB resulted in significant reduction of the heart rate, there was no difference between groups (p=0,61). 96,2% patients of group C and 95,5% of group M reached target levels of BP. Significant reduction of glucose (p&lt;0,01) and uric acid levels were registered in group C as well as tendency to lowering of total cholesterol (TC) and low density lipoprotein cholesterol (LDLC) levels. 34 adverse effects were registered during observation period: 24 in group C and 10 in group M (p&gt;0.05), half of them were not related to BB taking.Conclusion: Controlled antihypertensive therapy, based on С and M, allows reaching target levels of BP in majority of patients with overweight or obesity. Switching to combined therapy was made more seldom in group of С than in M group. Both drugs demonstrated metabolic neutrality, however significant lowering of glucose and uric acid levels and tendency to lowering of TC an LDLC levels was observed only in group С.</p

Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: The ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology

Aims: The aim of this study was to determine the contemporary use of reperfusion therapy in the European Society of Cardiology (ESC) member and affiliated countries and adherence to ESC clinical practice guidelines in patients with ST-elevation myocardial infarction (STEMI). Methods and results: Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset <24 h in 196 centres across 29 countries. A total of 11 462 patients were enrolled, for whom primary percutaneous coronary intervention (PCI) (total cohort frequency: 72.2%, country frequency range 0-100%), fibrinolysis (18.8%; 0-100%), and no reperfusion therapy (9.0%; 0-75%) were performed. Corresponding in-hospital mortality rates from any cause were 3.1%, 4.4%, and 14.1% and overall mortality was 4.4% (country range 2.5-5.9%). Achievement of quality indicators for reperfusion was reported for 92.7% (region range 84.8-97.5%) for the performance of reperfusion therapy of all patients with STEMI <12 h and 54.4% (region range 37.1-70.1%) for timely reperfusion. Conclusions: The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality